BELLEROPHON THERAPEUTICS INC's ticker is BLPH and the CUSIP is 078771102.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q4 2019 | $48,000 | -28.4% | 138,300 | 0.0% | 0.00% | – |
Q3 2019 | $67,000 | -14.1% | 138,300 | +5.7% | 0.00% | – |
Q2 2019 | $78,000 | +11.4% | 130,800 | +22.1% | 0.00% | – |
Q1 2019 | $70,000 | -5.4% | 107,150 | +15.9% | 0.00% | – |
Q4 2018 | $74,000 | -26.0% | 92,450 | 0.0% | 0.00% | – |
Q3 2018 | $100,000 | -34.2% | 92,450 | +47.2% | 0.00% | – |
Q2 2018 | $152,000 | +16.0% | 62,800 | 0.0% | 0.00% | – |
Q1 2018 | $131,000 | -19.1% | 62,800 | 0.0% | 0.00% | – |
Q4 2017 | $162,000 | +76.1% | 62,800 | -3.1% | 0.00% | – |
Q3 2017 | $92,000 | -27.6% | 64,800 | -31.9% | 0.00% | – |
Q2 2017 | $127,000 | -15.3% | 95,085 | -3.0% | 0.00% | -100.0% |
Q1 2017 | $150,000 | +194.1% | 98,035 | +3.2% | 0.00% | – |
Q4 2016 | $51,000 | -48.5% | 95,035 | +33.8% | 0.00% | -100.0% |
Q3 2016 | $99,000 | +23.8% | 71,035 | +46.2% | 0.00% | 0.0% |
Q2 2016 | $80,000 | -38.9% | 48,600 | -20.6% | 0.00% | – |
Q1 2016 | $131,000 | -27.2% | 61,246 | 0.0% | 0.00% | – |
Q4 2015 | $180,000 | +25.9% | 61,246 | +81.3% | 0.00% | -100.0% |
Q3 2015 | $143,000 | – | 33,773 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Puissance Capital Management LP | 8,298,755 | $6,651,000 | 7.59% |
NEW MOUNTAIN VANTAGE ADVISERS, L.L.C. | 15,138,486 | $16,953,000 | 1.88% |
VHCP Management II, LLC | 4,149,378 | $3,325,000 | 1.43% |
VHCP Management III, LLC | 2,274,370 | $1,823,000 | 1.32% |
ARCH Venture Management, LLC | 965,660 | $774,000 | 0.77% |
A.R.T. Advisors, LLC | 30,484 | $24,000 | 0.00% |
Virtu Financial LLC | 36,708 | $29,000 | 0.00% |
BRIDGEWAY CAPITAL MANAGEMENT, LLC | 183,000 | $147,000 | 0.00% |
GABLES CAPITAL MANAGEMENT INC. | 1,400 | $1,000 | 0.00% |
Renaissance Technologies | 1,255,476 | $1,006,000 | 0.00% |